pfizer inc (PFE:New York)
Morris J. Birnbaum M.D., Ph.D.
Chief Scientific Officer for Cardiovascular and Metabolic Disease Research, Pfizer Inc.
|Age||Total Calculated Compensation||This person is connected to 24 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Dr. Morris J. Birnbaum M.D., Ph.D. has been Chief Scientific Officer for Cardiovascular and Metabolic Disease Research at Pfizer Inc., since May 2014. Dr. Birnbaum is a Professor of Medicine, Cell and Development Biology at the University of Pennsylvania School of Medicine. He is an Investigator at the Howard Hughes Medical Institute. He serves as a Member of Scientific Advisory Board of Cymabay Therapeutics, Inc. and Motif Biosciences, Inc. He serves as a Member of ...
235 East 42nd StreetPhone: 212-733-2323
New York, New York 10017
Board Members Memberships*There is no Board Members Memberships data available.
University of California-San Francisco
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John C. Martin Ph.D.||Chairman and Chief Executive Officer|
Gilead Sciences Inc.
|Paul Bulcke B.E.||Chief Executive Officer, Member of Executive Board, Director and Member of Chairman's & Corporate Governance Committee|
|Alan George Lafley||Chairman, Chief Executive Officer, President and Member of Proxy Committee|
The Procter & Gamble Company
|Kenneth C. Frazier||Chairman, Chief Executive Officer and President|
Merck & Co. Inc.
|Severin Schwan Ph.D.||Chief Executive Officer and Director|
Roche Holding AG
|SFr.5.3M||Compensation as of Fiscal Year 2014.|